Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |